Regaine Männer Schaum

Regaine (known as Rogaine in the US) is a widely recognized brand for treating hereditary hair loss, specifically using the active ingredient Minoxidil. The brand was originally developed by the Upjohn Company in the United States after researchers discovered that a blood pressure medication had the side effect of stimulating hair growth.

Today, the brand is part of the Kenvue portfolio, which was spun off from Johnson & Johnson in 2023. While the brand has American roots, the products sold in the European and German markets are often manufactured in specialized pharmaceutical facilities in Italy. As a global pharmaceutical brand, it maintains high production standards under the ownership of Kenvue, a leading consumer health company.